[Federal Register Volume 64, Number 108 (Monday, June 7, 1999)]
[Notices]
[Pages 30347-30348]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 99-14374]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the meeting of
the National Cancer Advisory Board.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S. Code and Section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2). The grant applications and/or contract
proposals and the discussions could disclose confidential trade secrets
or commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Advisory Board.
Date: June 8, 1999.
Open: June 8, 1999, 8:30 a.m. to 4:00 p.m.
Agenda: Report of the Director, NCI; Reports and Presentations
Related to NCI Administrative and Program Developments;
Presentations and Discussions Related to Special Populations and
Quality of Care Issues; NCI Clinical Research Opportunities; NCAB
Subcommittee Meeting and NCAB Working Group Report; Legislative and
National Cancer Statistic Updates.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
[[Page 30348]]
Closed: June 8, 1999, 4:15 p.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: Building 31, C Wing, 6 Floor, Conference Room 10,
National Institutes of Health, 3100 Center Drive, Bethesda, MD
20892.
Contact Person: Dr. Marvin R. Kalt, Executive Secretary,
Director, Division of Extramural Activities, National Cancer
Institute, National Institutes of Health, Executive Plaza North,
Suite 600, 6130 Executive Boulevard, Rockville, MD 20892, (301) 496-
5147.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: June 1, 1999.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-14374 Filed 6-4-99; 8:45 am]
BILLING CODE 4140-01-M
